Literature DB >> 8152792

Partial inactivation of the RB product in a family with incomplete penetrance of familial retinoblastoma and benign retinal tumors.

R A Kratzke1, G A Otterson, A Hogg, A B Coxon, J Geradts, J K Cowell, F J Kaye.   

Abstract

While familial retinoblastoma has served as the paradigm for the two-hit theory of tumorigenesis and for the concept of the tumor suppressor gene, the etiology of incomplete penetrance of familial retinoblastoma is poorly understood. To address the molecular basis for this phenotype we have studied the functional properties of a mutant Rb gene identified in a kindred with incomplete penetrance of familial retinoblastoma and evidence for regressed retinal lesions (retinomas). In contrast to all previously isolated RB mutant proteins, we demonstrated that the mutant product from this kindred retained the wildtype properties of nuclear localization, the ability to undergo hyperphosphorylation in vivo, and the capacity to suppress growth of RB(-) cells. Protein binding ('pocket') activity, however, was defective defining a new class of RB mutant with partial inactivation. The presence of this unique RB mutant in the germline of obligate carriers with incomplete penetrance and regressed retinal lesions suggests a molecular basis for this phenotype and supports the hypothesis that a minimum 'RB threshold' level of protein binding activity is required to suppress tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8152792

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  22 in total

1.  pRB binds to and modulates the transrepressing activity of the E1A-regulated transcription factor p120E4F.

Authors:  L Fajas; C Paul; O Zugasti; L Le Cam; J Polanowska; E Fabbrizio; R Medema; M L Vignais; C Sardet
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

2.  Genetic interaction between Rb and K-ras in the control of differentiation and tumor suppression.

Authors:  Chiaki Takahashi; Bernardo Contreras; Roderick T Bronson; Massimo Loda; Mark E Ewen
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

3.  Deletion of RB exons 24 and 25 causes low-penetrance retinoblastoma.

Authors:  R Bremner; D C Du; M J Connolly-Wilson; P Bridge; K F Ahmad; H Mostachfi; D Rushlow; J M Dunn; B L Gallie
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

4.  Incomplete penetrance of familial retinoblastoma linked to germ-line mutations that result in partial loss of RB function.

Authors:  G A Otterson; W d Chen; A B Coxon; S N Khleif; F J Kaye
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

5.  Growth suppression by an E2F-binding-defective retinoblastoma protein (RB): contribution from the RB C pocket.

Authors:  L L Whitaker; H Su; R Baskaran; E S Knudsen; J Y Wang
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

6.  Induction of DNA synthesis and apoptosis by regulated inactivation of a temperature-sensitive retinoblastoma protein.

Authors:  F Tiemann; P W Hinds
Journal:  EMBO J       Date:  1998-02-16       Impact factor: 11.598

7.  Detection of allelic imbalance in the gene expression of hMSH2 or RB1 in lymphocytes from pedigrees of hereditary, nonpolyposis, colorectal cancer and retinoblastoma by an RNA difference plot.

Authors:  Yoshinori Murakami; Kana Isogai; Hiroyuki Tomita; Mika Sakurai-Yageta; Tomoko Maruyama; Akio Hidaka; Kiyoshi Nose; Kokichi Sugano; Akihiro Kaneko
Journal:  J Hum Genet       Date:  2004-10-08       Impact factor: 3.172

8.  Rb and N-ras function together to control differentiation in the mouse.

Authors:  Chiaki Takahashi; Roderick T Bronson; Merav Socolovsky; Bernardo Contreras; Kwang Youl Lee; Tyler Jacks; Makoto Noda; Raju Kucherlapati; Mark E Ewen
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

9.  Low-penetrant RB allele in small-cell cancer shows geldanamycin instability and discordant expression with mutant ras.

Authors:  Yoonsoo Park; Akihito Kubo; Takefumi Komiya; Amy Coxon; Kristin Beebe; Len Neckers; Paul S Meltzer; Frederic J Kaye
Journal:  Cell Cycle       Date:  2008-05-30       Impact factor: 4.534

10.  Germline mutations in retinoma patients: relevance to low-penetrance and low-expressivity molecular basis.

Authors:  Hana Abouzeid; Daniel F Schorderet; Aubin Balmer; Francis L Munier
Journal:  Mol Vis       Date:  2009-04-17       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.